Intellia Therapeutics, Inc.

NASDAQ:NTLA

22.52 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q2
Revenue 6.95728.935-1.91711.99213.59412.60613.57313.26614.0311.25212.8547.2046.556.4456.59522.2216.26312.91610.93610.61611.11810.4337.887.4087.6777.4696.6687.3175.9176.2155.6274.8694.2061.7771.6931.6881.3771.28600
Cost of Revenue 2.5992.5122.4662.292.172.052.0311.951.8371.7541.8860.48658.88439.27638.23139.75637.77134.6531.73127.51325.4623.70919.91823.23723.46722.49321.1717.48115.56513.43111.3317.8617.4235.2254.3753.4581.9661.3711.4750.011
Gross Profit 4.35826.423-4.3839.70211.42410.55611.54211.31612.1939.49810.974-53.282-52.334-32.831-31.636-17.536-21.508-21.734-20.795-16.897-14.342-13.276-12.038-15.829-15.79-15.024-14.502-10.164-9.648-7.216-5.704-2.992-3.217-3.448-2.682-1.77-0.589-0.085-1.475-0.011
Gross Profit Ratio 0.6260.9132.2860.8090.840.8370.850.8530.8690.8440.854-7.396-7.99-5.094-4.797-0.789-1.323-1.683-1.902-1.592-1.29-1.273-1.528-2.137-2.057-2.012-2.175-1.389-1.631-1.161-1.014-0.614-0.765-1.94-1.584-1.049-0.428-0.06600
Reseach & Development Expenses 111.608109.335108.981113.696115.27697.116100.03496.65190.199133.09571.16160.48658.88439.27638.23139.75637.77134.6531.73127.51325.4623.70919.91823.23723.46722.49321.1717.48115.56513.43111.3317.8617.4235.2254.3753.4581.9661.3714.5020.011
General & Administrative Expenses 31.79331.09128.99429.40330.65227.44823.62622.14522.13222.40322.10818.71116.68313.59410.76310.56611.52611.3148.9768.43113.11810.5338.7088.277.8057.40610.2135.7116.3695.7325.1184.7053.7293.2462.8091.5312.8331.112.7150.167
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 31.79331.09128.99429.40330.65227.44823.62622.14522.13222.40322.10818.71116.68313.59410.76310.56611.52611.3148.9768.43113.11810.5338.7088.277.8057.40610.2135.7116.3695.7325.1184.7053.7293.2462.8091.5312.8331.112.7150.167
Other Expenses 0000000000000000000000000000000000000000
Operating Expenses 143.401140.426137.975143.099145.928124.564123.66118.796112.331155.49893.26979.19775.56752.8748.99450.32249.29745.96440.70735.94438.57834.24228.62631.50731.27229.89931.38323.19221.93419.16316.44912.56611.1528.4717.1844.9894.7992.4815.7420.167
Operating Income -139.043-114.003-139.892-131.107-132.334-111.958-110.087-105.53-98.301-144.246-80.415-71.993-69.017-46.425-42.399-28.102-33.034-33.048-29.771-25.328-27.46-23.809-20.746-24.099-23.595-22.43-24.715-15.875-16.017-12.948-10.822-7.697-6.946-6.694-5.491-3.301-3.422-1.195-4.189-0.178
Operating Income Ratio -19.986-3.9472.974-10.933-9.735-8.881-8.111-7.955-7.006-12.82-6.256-9.993-10.537-7.203-6.429-1.265-2.031-2.559-2.722-2.386-2.47-2.282-2.633-3.253-3.073-3.003-3.707-2.17-2.707-2.083-1.923-1.581-1.651-3.767-3.243-1.956-2.485-0.92900
Total Other Income Expenses Net -7.9326.567-4.728-3.857-48.832-3.32-7.699-2.377-3.166-1.3250.3490.2110.220.2070.2620.6411.2421.4951.6941.7771.8691.681.3971.3761.0740.7520.5190.4240.3170.2590.2150.0460.0050000-3.0280
Income Before Tax -146.975-107.436-132.161-122.224-123.681-103.126-113.407-113.229-100.678-146.872-81.237-71.644-68.806-46.205-42.192-27.84-32.393-31.806-28.276-23.634-25.683-21.94-19.066-22.702-22.219-21.356-23.963-15.356-15.593-12.631-10.563-7.482-6.9-6.689-5.491-3.301-3.422-1.195-7.217-0.178
Income Before Tax Ratio -21.126-3.71368.942-10.192-9.098-8.181-8.355-8.535-7.176-13.053-6.32-9.945-10.505-7.169-6.398-1.253-1.992-2.463-2.586-2.226-2.31-2.103-2.42-3.065-2.894-2.859-3.594-2.099-2.635-2.032-1.877-1.537-1.641-3.764-3.243-1.956-2.485-0.92900
Income Tax Expense 02.46940.635-15.03-14.823-10.7823.32-1.945-0.703-0.119-2.383000-1.6020000000-1.227000-0.833000-0.405000-0.246-0.282-0.382-0.10200
Net Income -146.975-107.436-132.161-122.224-123.681-92.344-116.727-111.284-99.975-146.872-81.237-71.644-68.806-46.205-42.192-27.84-32.393-31.806-28.276-23.634-25.683-21.94-19.066-22.702-22.219-21.356-23.963-15.356-15.593-12.631-10.563-7.482-6.9-6.689-5.245-3.019-3.04-1.093-7.217-0.178
Net Income Ratio -21.126-3.71368.942-10.192-9.098-7.325-8.6-8.389-7.126-13.053-6.32-9.945-10.505-7.169-6.398-1.253-1.992-2.463-2.586-2.226-2.31-2.103-2.42-3.065-2.894-2.859-3.594-2.099-2.635-2.032-1.877-1.537-1.641-3.764-3.098-1.789-2.208-0.8500
EPS -1.52-1.12-1.46-1.38-1.4-1.05-1.44-1.46-1.32-1.96-1.09-0.97-1.01-0.69-0.69-0.47-0.61-0.63-0.57-0.49-0.56-0.49-0.43-0.53-0.52-0.51-0.61-0.44-0.45-0.36-0.31-0.22-0.36-0.2-0.3-0.17-0.17-0.062-2.48-0.061
EPS Diluted -1.52-1.12-1.46-1.38-1.4-1.05-1.44-1.46-1.32-1.96-1.09-0.97-1.01-0.69-0.69-0.47-0.61-0.63-0.57-0.49-0.56-0.49-0.43-0.53-0.52-0.51-0.61-0.44-0.45-0.36-0.31-0.22-0.36-0.2-0.3-0.17-0.17-0.062-2.48-0.061
EBITDA -136.444-111.491-137.426-131.107-132.334-111.858-104.661-95.77-98.473-142.071-80.415-70.207-67.383-44.834-42.399-26.5-31.468-31.507-28.188-23.945-26.138-22.51-20.746-22.947-22.522-21.418-24.715-15.085-15.306-12.288-10.822-7.432-6.699-6.507-5.359-3.205-3.355-1.162-4.1880
EBITDA Ratio -19.612-3.85371.688-10.933-9.735-8.873-7.711-7.219-7.019-12.626-6.256-9.746-10.287-6.956-6.429-1.193-1.935-2.439-2.578-2.256-2.351-2.158-2.633-3.098-2.934-2.868-3.707-2.062-2.587-1.977-1.923-1.526-1.593-3.662-3.165-1.899-2.436-0.90400